This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Alberta directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $895,050
Ontogeny of T cell control by BTLA and PD-1
CIHR · 2022 · Nominated PI
- $753,035
Co-inhibitory control of tolerance checkpoints
CIHR · 2016 · Nominated PI
- $17,500
The Role of Co-Inhibitory Molecules in the Innate Immune System
CIHR · 2009 · Supervisor
Ontogeny of T cell control by BTLA and PD-1
Principal investigators: Anderson, Colin C; Baldwin, Troy A
Keywords: Autoimmune Disease; Immunologic Tolerance
Co-inhibitory control of tolerance checkpoints
Principal investigators: Anderson, Colin C
Keywords: Autoimmune Disease; Diabetes; Flow Cytometry; Immunology; Tolerance; Transplantation
The Role of Co-Inhibitory Molecules in the Innate Immune System
Principal investigators: Smolarchuk, Christa D
Keywords: Co-Inhibitory Receptors; Immunology; Innate; Islet Transplantation; Type 1 Diabetes
Mechanisms of natural peripheral tolerance of self and alloantigens
Principal investigators: Anderson, Colin C
Keywords: Diabetes; Flow Cytometry; Immunology; Tolerance; Transplantation
The Interactions of Circulating Bone Marrow Derived Cells and Stromal Fibroblasts in Fibroproliferative Disorders of the Skin
Principal investigators: Tredget, Edward E
Keywords: Cytokines / Chemokines; Fibrocytes; Fibroproliferative Disorders / Hypertrophic Scarring; Reticular Fibroblasts; Th1 / Th2 / Th3 Response; Transforming Growth Factor-Beta
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.